Drugmaker AbbVie's profit beats estimates on strong Humira sales

April 23, 2015 1:32 PM

3 0

Drugmaker AbbVie's profit beats estimates on strong Humira sales

(Reuters) - U.S. drugmaker AbbVie Inc reported better-than-expected quarterly profit and revenue, driven by strong sales of its arthritis drug, Humira.

Shares of the company, which also raised its full-year adjusted profit forecast, rose about 2 percent to $65.69 in premarket trading on Thursday.

Read more

To category page

Loading...